phosphorus has been researched along with naltrexone in 1 studies
Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (naltrexone) | Trials (naltrexone) | Recent Studies (post-2010) (naltrexone) |
---|---|---|---|---|---|
48,074 | 1,126 | 17,139 | 8,745 | 1,228 | 2,642 |
Protein | Taxonomy | phosphorus (IC50) | naltrexone (IC50) |
---|---|---|---|
Cytochrome P450 2D6 | Homo sapiens (human) | 1 | |
Delta-type opioid receptor | Mus musculus (house mouse) | 0.0051 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0063 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.006 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
Mu-type opioid receptor | Homo sapiens (human) | 0.006 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.0319 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0093 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.0377 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 0.0076 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0004 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faden, AI; McIntosh, TK; Rhomhanyi, R; Vink, R | 1 |
1 other study(ies) available for phosphorus and naltrexone
Article | Year |
---|---|
Opiate antagonist nalmefene improves intracellular free Mg2+, bioenergetic state, and neurologic outcome following traumatic brain injury in rats.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Brain Injuries; Disease Models, Animal; Energy Metabolism; Magnesium; Magnetic Resonance Spectroscopy; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Phosphates; Phosphocreatine; Phosphorus; Rats; Rats, Inbred Strains | 1990 |